Elsevier

Neurobiology of Aging

Volume 37, January 2016, Pages 47-57
Neurobiology of Aging

Regular article
The APOE4 allele shows opposite sex bias in microbleeds and Alzheimer's disease of humans and mice

https://doi.org/10.1016/j.neurobiolaging.2015.10.010Get rights and content

Abstract

The apolipoprotein APOE4 allele confers greater risk of Alzheimer's disease (AD) for women than men, in conjunction with greater clinical deficits per unit of AD neuropathology (plaques, tangles). Cerebral microbleeds, which contribute to cognitive dysfunctions during AD, also show APOE4 excess, but sex-APOE allele interactions are not described. We report that elderly men diagnosed for mild cognitive impairment and AD showed a higher risk of cerebral cortex microbleeds with APOE4 allele dose effect in 2 clinical cohorts (ADNI and KIDS). Sex-APOE interactions were further analyzed in EFAD mice carrying human APOE alleles and familial AD genes (5XFAD +/- /human APOE+/+). At 7 months, E4FAD mice had cerebral cortex microbleeds with female excess, in contrast to humans. Cerebral amyloid angiopathy, plaques, and soluble Aβ also showed female excess. Both the cerebral microbleeds and cerebral amyloid angiopathy increased in proportion to individual Aβ load. In humans, the opposite sex bias of APOE4 allele for microbleeds versus the plaques and tangles is the first example of organ-specific, sex-linked APOE allele effects, and further shows AD as a uniquely human condition.

Introduction

The APOE4 allele is the strongest heritable risk factor for sporadic Alzheimer's disease (AD), with sex-bias of >50% for women (Altmann et al., 2014, Farrer et al., 1997, Payami et al., 1996). The neuropathological load showed parallel sex and apolipoprotein E (APOE) differences in benchmark postmortem studies of AD brains, with female excess of senile plaques and of neurofibrillary tangles (NFT) (Barnes et al., 2005, Corder et al., 2004). Moreover, women incurred 5-fold greater cognitive deficits per unit of brain β-amyloid (Aβ) than men (Barnes et al., 2005). Other studies also show female excess vulnerability in brain aging, with 1%–1.5% faster brain atrophy in magnetic resonance imaging (MRI) studies of probable AD (Hua et al., 2010), and higher tau in cerebrospinal fluid of prodromal AD (mild cognitive impairment [MCI]) (Altmann et al., 2014), but also in cognitively healthy elderly (Damoiseaux et al., 2012). Correspondingly, women APOE4 carriers had excess of Aβ plaque and NFT (Barnes et al., 2005, Corder et al., 2004) and more hippocampal atrophy in prodromal AD (Fleisher et al., 2005). Mouse transgenic models of AD with familial AD mutations (FAD) have shown consistent female excess of brain Aβ and cognitive deficits (Carroll et al., 2010, Dubal et al., 2012, Sturchler-Pierrat and Staufenbiel, 2000, Vest and Pike, 2013).

In contrast to brain Aβ and NFT, cerebral microbleeds (microhemorrhages) typically show male 50% excess, for example, in the Karolinska Imaging Dementia Study (KIDS) for AD (Shams et al., 2015) and the Amsterdam Dementia Cohort (Benedictus et al., 2015). Microbleeds, together with cerebral amyloid angiopathy (CAA) (Shams et al., 2015), are of emerging importance as a contributing factor to preclinical cognitive decline and as an additional clinical burden in AD (Meier et al., 2014, Reijmer et al., 2015). In cognitively normal elderly, the presence of cerebral cortex microbleeds was associated with lower resting-state cerebral blood flow and subtle cognitive deficits (Gregg et al., 2015). APOE4 is also associated with cerebral microbleeds (Resnick et al., 2015, Yates et al., 2014) and CAA in leptomeningeal and cerebral cortex vessels (Resnick et al., 2015, Schmechel et al., 1993). Because microbleeds are associated with CAA (Rannikmae et al., 2013, Yates et al., 2014), it is cogent to evaluate their association with sex. Some postmortem studies show a slight female excess of CAA (Lee and Stemmermann, 1978, Masuda et al., 1988) that was not seen in other samples (Allen et al., 2014, Gilbert and Vinters, 1983, Love et al., 2003). FAD mice develop CAA (Fryer et al., 2005) but sex differences and interactions of FAD with human APOE transgenes are not reported.

AD may have uniquely evolved in humans, because no FAD rodent or aging primate has clinical grade AD-like cognitive impairment with major neuron loss (Finch and Austad, 2015). Although aging great apes develop CAA (Gearing et al., 1994) and incur sporadic strokes (Jean et al., 2012, Shams et al., 2015), no aging wildtype rodent has shown CAA or stroke (Sullivan et al., 2008). Wildtype rodents are famously resistant to diet-induced atherosclerosis, unless made hypercholesterolemic by lipoprotein gene knockout, for example, APOE-KO mice on high cholesterol diets developed aortic atheromas and intimal-media thickening (Smith et al., 2010). However, spontaneous cerebrovascular ischemic lesions are unknown in lab rodents even with induced hypercholesterolemia. Thus, 4 major pathologic changes associated with human brain aging and AD have not been reported for aging wildtype rodents: brain Aβ-amyloid deposits, major neurodegeneration or neuron loss, CAA, and cerebrovascular ischemic lesions. One clue may be in APOE differences by species.

Humans have a unique multiallele APOE system, whereas the primates and rodents examined so far have a single APOE isoform which resembles APOE4 in some amino acid positions (Fullerton et al., 2000, McIntosh et al., 2012). Notably during aging, APOE-targeted replacement (TR) mice transgenic for human APOE by TR (knock-in) developed gross lobar hemorrhages by 18 months (41% of APOE4-TR; 8% of APOE3-TR) (Sullivan et al., 2008). Moreover, these hemorrhages were associated with classic CAA. The vascular thioflavin-positive fibrillar amyloid on wildtype background was unexpected because the endogenous murine Aβ has lower aggregatability than human Aβ (Boyd-Kimball et al., 2004). The greater prevalence of CAA in APOE4- versus E3-TR is consistent with findings from mice transgenic for the combination of FAD genes together human APOE, in which APOE4 increased CAA and plaques above APOE3 (Fryer et al., 2005). These studies did not examine sex differences.

To extend the correlations of Aβ with CAA for sex-APOE allele interactions in FAD mice and in human AD (see the previous paragraphs), we used the EFAD mice, which are 5XFAD+/−/human APOE+/+ (E3FAD, E4FAD) (for derivation, see Youmans et al., 2012). Previous publications demonstrated that by immunochemistry, male EFAD mice accumulate significant extracellular Aβ in the subiculum and then deep layers of the frontal cortex from 2 to 6 months of age, with E4FAD > E3FAD (Youmans et al., 2012). In addition, soluble levels of Aβ42 and oligomeric Aβ (oAβ) in both the hippocampus and cortex are higher in E4FAD compared to E3FAD mice (Youmans et al., 2012). The early deposition of Aβ in EFAD mice gives an attractive model to study quantitative relationships between CAA and the Aβ load at young ages before changes in sex steroids. Cerebral cortex was analyzed at age 7 months for sex-APOE interactions in microbleeds and CAA, and for correlations with plaque Aβ. We also assayed oligomeric Aβ, a driver of neurodegeneration in AD (Klein et al., 2011, Mucke and Selkoe, 2012), which has not been reported for associations with sex or APOE in mouse models. Novel sex-APOE allele interactions were found in microvascular pathologies of brain aging that differ from AD, with species differences that may arise during sexual differentiation.

Section snippets

Subjects

Informed written consent was obtained from all participants at each site (Fig. 1, Table 1, Table 2, Table 3, Table 4).

Humans

Because sex-APOE interactions for human microbleeds have not been reported, we interrogated 2 clinical MRI studies of well-characterized elderly for microbleeds: the ADNI Study, a longitudinal MRI study of a large North American cohort, and the Karolinska Imaging Dementia Study (KIDS), a cross-sectional cohort study (Section 2.1; Tables 1 and 2). In both ADNI and KIDS, APOE3 homozygotes did not differ by sex in microbleeds. Both ADNI and KIDS male subjects carrying APOE4 had more microbleeds;

Discussion

We report novel sex-APOE allele interactions for cerebral microbleeds and for brain Aβ amyloid levels with species differences. Microbleeds were analyzed from 2 clinical MRI imaging studies from different national populations (ADNI, U.S and Canada; KIDS, Sweden). In both ADNI and KIDS, elderly men with clinical grade symptoms of MCI or AD had 2-fold more microbleeds than women, with APOE4 allele effects. The control groups had much fewer microbleeds in both ADNI and KIDS and did not show sex or

Conclusion

For both humans and mice, APOE4 interacted with sex differences of microbleeds and Aβ levels. Comparison of human brain aging with mouse models reveals major gaps in our understanding of sex differences across species: aging men incur several-fold more microbleeds than women, opposite to male EFAD mice which had several-fold fewer. For CAA, the EFAD mice showed modest female excess in prevalence of Aβ-positive vessels, agreeing with some postmortem human studies. Because the mouse sex

Disclosure statement

The authors have no conflicts of interest to disclose.

Acknowledgements

Experimental studies on mice were supported by the NIA: R21-AG040683 (CEF); P01-AG026572 (R.D.Brinton): Project 2 (CEF), Project 3 (CJP), P01AG044682 (MJL), R21AG030128 (MJL), R21AG048498 (MJL), UL1RR029879 (CCTS), ADDF (MJL). Imaging studies were supported by the NIA: P01-AG05142 (H. Chui). Alzheimer’s Disease Neuroimaging Initiative (ADNI) (NIA U01 AG-024904; DOD W81XWH-12-2–0012). ADNI is also funded by the National Institute of Biomedical Imaging and Bioengineering, and through generous

References (86)

  • P.M. Sullivan et al.

    Human apolipoprotein E4 targeted replacement mice show increased prevalence of intracerebral hemorrhage associated with vascular amyloid deposition

    J. Stroke Cerebrovasc. Dis.

    (2008)
  • P.M. Sullivan et al.

    Targeted replacement of the mouse apolipoprotein E gene with the common human APOE3 allele enhances diet-induced hypercholesterolemia and atherosclerosis

    J. Biol. Chem.

    (1997)
  • R.S. Vest et al.

    Gender, sex steroid hormones, and Alzheimer's disease

    Horm. Behav.

    (2013)
  • J.M. Wardlaw et al.

    STandards for ReportIng Vascular changes on nEuroimaging (STRIVE v1), Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration

    Lancet Neurol.

    (2013)
  • K.L. Youmans et al.

    APOE4-specific changes in Abeta accumulation in a new transgenic mouse model of Alzheimer disease

    J. Biol. Chem.

    (2012)
  • N. Allen et al.

    Patterns of cerebral amyloid angiopathy define histopathological phenotypes in Alzheimer's disease

    Neuropathol. Appl. Neurobiol.

    (2014)
  • A. Altmann et al.

    Sex modifies the APOE-related risk of developing Alzheimer disease

    Ann. Neurol.

    (2014)
  • O.G. Azevedo et al.

    Apolipoprotein E plays a key role against cryptosporidial infection in transgenic undernourished mice

    PLoS One

    (2014)
  • L.L. Barnes et al.

    Sex differences in the clinical manifestations of Alzheimer disease pathology

    Arch. Gen. Psychiatry

    (2005)
  • R.D. Bell et al.

    Apolipoprotein E controls cerebrovascular integrity via cyclophilin A

    Nature

    (2012)
  • H. Beltrán-Sanchez et al.

    The 20th Century surge of excess adult male mortality

    Proc. Natl. Acad. Sci. U. S. A.

    (2015)
  • M.R. Benedictus et al.

    Microbleeds, Mortality, and Stroke in Alzheimer Disease: The MISTRAL Study

    JAMA Neurol.

    (2015)
  • L. Berg et al.

    Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype

    Arch. Neurol.

    (1998)
  • D. Boyd-Kimball et al.

    Rodent Abeta(1-42) exhibits oxidative stress properties similar to those of human Abeta(1-42): implications for proposed mechanisms of toxicity

    J. Alzheimers Dis.

    (2004)
  • B. Caracciolo et al.

    Differential distribution of subjective and objective cognitive impairment in the population: a nation-wide twin-study

    J. Alzheimers Dis.

    (2012)
  • Y.W. Chen et al.

    Cerebral amyloid angiopathy in East and West

    Int. J. Stroke

    (2010)
  • J.Y. Chuang et al.

    Interactions between amyloid-beta and hemoglobin: implications for amyloid plaque formation in Alzheimer's disease

    PLoS One

    (2012)
  • E.H. Corder et al.

    The biphasic relationship between regional brain senile plaque and neurofibrillary tangle distributions: modification by age, sex, and APOE polymorphism

    Ann. N. Y. Acad. Sci.

    (2004)
  • J.S. Damoiseaux et al.

    Alzheimer's Disease Neuroimaging, Gender modulates the APOE epsilon4 effect in healthy older adults: convergent evidence from functional brain connectivity 516 and spinal fluid tau levels

    J. Neurosci.

    (2012)
  • B. De Strooper et al.

    Production of intracellular amyloid-containing fragments in hippocampal neurons expressing human amyloid precursor protein and protection against amyloidogenesis by subtle amino acid substitutions in the rodent sequence

    EMBO J.

    (1995)
  • J. Ding et al.

    Risk Factors Associated With Incident Cerebral Microbleeds According to Location in Older People: The Age, Gene/Environment Susceptibility (AGES)- Reykjavik Study

    JAMA Neurol.

    (2015)
  • D.B. Dubal et al.

    Sex and gonadal hormones in mouse models of Alzheimer's disease: what is relevant to the human condition?

    Biol. Sex. Diff.

    (2012)
  • A. Dumas et al.

    Functional magnetic resonance imaging detection of vascular reactivity in cerebral amyloid angiopathy

    Ann. Neurol.

    (2012)
  • S.L. Fairbanks et al.

    Sex stratified neuronal cultures to study ischemic cell death pathways

    J. Vis. Exp.

    (2013)
  • L.A. Farrer et al.

    Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium

    JAMA

    (1997)
  • C.E. Finch et al.

    Dementias of the Alzheimer type: views through the lens of evolutionary biology suggest amyloid-driven brain aging is a trade-off with host defence

  • C.E. Finch et al.

    Systemic inflammation, infection, ApoE alleles, and Alzheimer disease: a position paper

    Curr. Alzheimer Res.

    (2007)
  • A. Fleisher et al.

    Sex, apolipoprotein E epsilon 4 status, and hippocampal volume in mild cognitive impairment

    Arch. Neurol.

    (2005)
  • J.D. Fryer et al.

    Human apolipoprotein E4 alters the amyloid-beta 40:42 ratio and promotes the formation of cerebral amyloid angiopathy in an amyloid precursor protein transgenic model

    J. Neurosci.

    (2005)
  • M. Gearing et al.

    Neuropathology and apolipoprotein E profile of aged chimpanzees: implications for Alzheimer disease

    Proc. Natl. Acad. Sci. U. S. A.

    (1994)
  • J.J. Gilbert et al.

    Cerebral amyloid angiopathy: incidence and complications in the aging brain. I. Cerebral hemorrhage

    Stroke

    (1983)
  • A.S. Go et al.

    Heart disease and stroke statistics–2013 update: a report from the American Heart Association

    Circulation

    (2013)
  • R.A. Gorski

    The neuroendocrinology of reproduction: an overview

    Biol. Reprod.

    (1979)
  • Cited by (0)

    1

    Data used in preparation of this article were obtained from the Alzheimer's Disease Neuroimaging Initiative (ADNI) database (adni.loni.usc.edu). As such, the investigators within the ADNI contributed to the design and implementation of ADNI and/or provided data but did not participate in analysis or writing of this report. Complete listing of ADNI investigators: http://adni.loni.usc.edu/wpcontent/uploads/how_to_apply/ADNI_Acknowledgement_List.pdf

    View full text